{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:05Z","timestamp":1791999305940,"version":"4.4.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS105741"],"award-info":[{"award-number":["R01NS105741"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Adelson Medical Research Foundation","doi-asserted-by":"publisher","award":["A130141"],"award-info":[{"award-number":["A130141"]}],"id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rachleff family endowment"},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2013\/B\/4"],"award-info":[{"award-number":["2013\/B\/4"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Many biomarkers in clinical neuroscience lack pathological certification. This issue is potentially a significant contributor to the limited success of neuroprotective and neurorestorative therapies for human neurological disease\u2014and is evident even in areas with therapeutic promise such as myelin repair. Despite the identification of promising remyelinating candidates, biologically validated methods to demonstrate therapeutic efficacy or provide robust preclinical evidence of remyelination in the CNS are lacking. Therapies with potential to remyelinate the CNS constitute one of the most promising and highly anticipated therapeutic developments in the pipeline to treat multiple sclerosis and other demyelinating diseases. The optic nerve has been proposed as an informative pathway to monitor remyelination in animals and human subjects. Recent clinical trials using visual evoked potential have had promising results, but without unequivocal evidence about the cellular and molecular basis for signal changes on visual evoked potential, the interpretation of these trials is constrained. The visual evoked potential was originally developed and used in the clinic as a diagnostic tool but its use as a quantitative method for assessing therapeutic response requires certification of its biological specificity. Here, using the tools of experimental pathology we demonstrate that quantitative measurements of myelination using both histopathological measures of nodal structure and ultrastructural assessments correspond to visual evoked potential latency in both inflammatory and chemical models of demyelination. Visual evoked potential latency improves after treatment with a tool remyelinating compound (clemastine), mirroring both quantitative and qualitative myelin assessment. Furthermore, clemastine does not improve visual evoked potential latency following demyelinating injury when administered to a transgenic animal incapable of forming new myelin. Therefore, using the capacity for therapeutic enhancement and biological loss of function we demonstrate conclusively that visual evoked potential measures myelin status and is thereby a validated tool for preclinical verification of remyelination.<\/jats:p>","DOI":"10.1093\/brain\/awac207","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T08:30:33Z","timestamp":1654763433000},"page":"3943-3952","source":"Crossref","is-referenced-by-count":70,"title":["Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy"],"prefix":"10.1093","volume":"145","author":[{"given":"Christian","family":"Cordano","sequence":"first","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung H","family":"Sin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Timmons","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao H","family":"Yiu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stebbins","sequence":"additional","affiliation":[{"name":"Inception Sciences , San Diego, CA 92121 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Guglielmetti","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Cruz-Herranz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lorrain","sequence":"additional","affiliation":[{"name":"Inception Sciences , San Diego, CA 92121 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-1242","authenticated-orcid":false,"given":"Jonah R","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari J","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"2023053018553292400_awac207-B1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat Med"},{"key":"2023053018553292400_awac207-B2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"2023053018553292400_awac207-B3","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"2023053018553292400_awac207-B4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0361-9230(93)90319-7","article-title":"Flash and pattern reversal visual evoked potentials in C57BL\/6J and B6CBAF1\/J mice","volume":"32","author":"Strain","year":"1993","journal-title":"Brain Res Bull"},{"key":"2023053018553292400_awac207-B5","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.visres.2005.09.006","article-title":"The visual evoked potential in the mouse\u2013origins and response characteristics","volume":"46","author":"Ridder","year":"2006","journal-title":"Vision Res"},{"key":"2023053018553292400_awac207-B6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): A randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol"},{"key":"2023053018553292400_awac207-B7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): A randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"Brown","year":"2021","journal-title":"Lancet Neurol"},{"key":"2023053018553292400_awac207-B8","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1167\/iovs.12-10559","article-title":"Visual functional and histopathological correlation in experimental autoimmune optic neuritis","volume":"53","author":"Matsunaga","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023053018553292400_awac207-B9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-510X(83)90130-2","article-title":"Visual evoked potentials in experimental allergic encephalomyelitis","volume":"60","author":"Bilbool","year":"1983","journal-title":"J Neurol Sci"},{"key":"2023053018553292400_awac207-B10","first-page":"125","article-title":"Evoked potentials (EPs) in experimental allergic encephalomyelitis: A study of EP modifications during the course of a controlled disease","volume":"32","author":"Onofrj","year":"1992","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"2023053018553292400_awac207-B11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2007.06.023","article-title":"FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis","volume":"74","author":"Balatoni","year":"2007","journal-title":"Brain Res Bull"},{"key":"2023053018553292400_awac207-B12","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1167\/iovs.08-1896","article-title":"Autoimmune optic neuritis in the common marmoset monkey: Comparison of visual evoked potentials with MRI and histopathology","volume":"49","author":"Diem","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023053018553292400_awac207-B13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2010.07.026","article-title":"Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination","volume":"1351","author":"Mozafari","year":"2010","journal-title":"Brain Res"},{"key":"2023053018553292400_awac207-B14","doi-asserted-by":"crossref","first-page":"27074","DOI":"10.1073\/pnas.1906358116","article-title":"Evoked potentials as a biomarker of remyelination","volume":"116","author":"Heidari","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023053018553292400_awac207-B15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-019-1583-4","article-title":"Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis","volume":"16","author":"Cruz-Herranz","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2023053018553292400_awac207-B16","doi-asserted-by":"crossref","first-page":"e18246","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"eLife"},{"key":"2023053018553292400_awac207-B17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann Neurol"},{"key":"2023053018553292400_awac207-B18","doi-asserted-by":"crossref","first-page":"e2025795118","DOI":"10.1073\/pnas.2025795118","article-title":"Live imaging of remyelination in the adult mouse corpus callosum","volume":"118","author":"Bottes","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023053018553292400_awac207-B19","doi-asserted-by":"crossref","first-page":"116012","DOI":"10.1117\/1.3662945","article-title":"Single myelin fiber imaging in living rodents without labeling by deep optical coherence microscopy","volume":"16","author":"Arous J","year":"2011","journal-title":"J Biomed Opt"},{"key":"2023053018553292400_awac207-B20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bpj.2011.01.031","article-title":"In vivo imaging of myelin in the vertebrate central nervous system using third harmonic generation microscopy","volume":"100","author":"Farrar","year":"2011","journal-title":"Biophys J"},{"key":"2023053018553292400_awac207-B21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nm.3495","article-title":"Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy","volume":"20","author":"Schain","year":"2014","journal-title":"Nat Med"},{"key":"2023053018553292400_awac207-B22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1529\/biophysj.105.061911","article-title":"Coherent anti-stokes Raman scattering imaging of axonal myelin in live spinal tissues","volume":"89","author":"Wang","year":"2005","journal-title":"Biophys J"},{"key":"2023053018553292400_awac207-B23","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.neuron.2021.08.015","article-title":"Experience-dependent myelination following stress is mediated by the neuropeptide dynorphin","volume":"109","author":"Osso","year":"2021","journal-title":"Neuron"},{"key":"2023053018553292400_awac207-B24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/38.5.1692056","article-title":"A rapid, sensitive histochemical stain for myelin in frozen brain sections","volume":"38","author":"Schmued","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"2023053018553292400_awac207-B25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41583-020-00406-8","article-title":"Mechanisms of node of Ranvier assembly","volume":"22","author":"Rasband","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"2023053018553292400_awac207-B26","doi-asserted-by":"crossref","first-page":"e87736","DOI":"10.1371\/journal.pone.0087736","article-title":"Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination","volume":"9","author":"Bagchi","year":"2014","journal-title":"PLoS ONE"},{"key":"2023053018553292400_awac207-B27","doi-asserted-by":"crossref","first-page":"e1395","DOI":"10.1038\/cddis.2014.357","article-title":"Dock3 protects myelin in the cuprizone model for demyelination","volume":"5","author":"Namekata","year":"2014","journal-title":"Cell Death Dis"},{"key":"2023053018553292400_awac207-B28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00418-018-1654-0","article-title":"Changes in the axo-glial junctions of the optic nerves of cuprizone-treated mice","volume":"149","author":"Kojima","year":"2018","journal-title":"Histochem Cell Biol"},{"key":"2023053018553292400_awac207-B29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.1254960","article-title":"Motor skill learning requires active central myelination","volume":"346","author":"McKenzie","year":"2014","journal-title":"Science"},{"key":"2023053018553292400_awac207-B30","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"2023053018553292400_awac207-B31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1749-6632.1998.tb09609.x","article-title":"Neuroendocrine influences on experimental autoimmune encephalomyelitis","volume":"840","author":"Whitacre","year":"1998","journal-title":"Ann N Y Acad Sci"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awac207\/45403083\/awac207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/11\/3943\/50491183\/awac207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/11\/3943\/50491183\/awac207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:56:21Z","timestamp":1685458581000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/11\/3943\/6604766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6,9]]},"published-print":{"date-parts":[[2022,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awac207","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,6,9]]}}}